134
Participants
Start Date
December 31, 2011
Primary Completion Date
August 31, 2013
Study Completion Date
October 31, 2013
Pitavastin 4mg
Atorvastatin 20mg
Rosuvastatin 5mg
University of Kansas Medical Center, Kansas City
Collaborators (1)
Kowa Pharmaceuticals America, Inc.
INDUSTRY
Eli Lilly and Company
INDUSTRY
University of Kansas Medical Center
OTHER